The Beauty Health Company (NASDAQ:SKIN) Receives $2.42 Average Price Target from Brokerages

Shares of The Beauty Health Company (NASDAQ:SKIN) have earned a consensus rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $2.42.

SKIN has been the subject of several research reports. Jefferies Financial Group reiterated a “hold” rating and set a $1.60 price target on shares of Beauty Health in a report on Wednesday, January 14th. Canaccord Genuity Group restated a “hold” rating and issued a $1.50 price objective on shares of Beauty Health in a report on Friday, March 13th. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday. Finally, TD Cowen decreased their target price on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research report on Monday.

Institutional Investors Weigh In On Beauty Health

A number of large investors have recently bought and sold shares of SKIN. Mirabella Financial Services LLP increased its position in Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after buying an additional 2,734,728 shares during the last quarter. Woodline Partners LP lifted its position in shares of Beauty Health by 255.9% in the third quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock worth $11,801,000 after buying an additional 4,263,997 shares during the last quarter. Millennium Management LLC lifted its position in shares of Beauty Health by 127.0% in the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock worth $8,013,000 after buying an additional 3,225,668 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Beauty Health by 27.5% during the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after acquiring an additional 496,963 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Beauty Health by 0.9% during the 4th quarter. State Street Corp now owns 1,871,527 shares of the company’s stock worth $2,601,000 after acquiring an additional 16,493 shares in the last quarter. 93.26% of the stock is currently owned by institutional investors.

Beauty Health Trading Down 1.7%

NASDAQ SKIN opened at $1.16 on Tuesday. The company has a current ratio of 1.66, a quick ratio of 1.40 and a debt-to-equity ratio of 3.94. Beauty Health has a 1-year low of $0.78 and a 1-year high of $2.69. The firm’s fifty day simple moving average is $1.25 and its 200-day simple moving average is $1.49. The company has a market capitalization of $147.90 million, a PE ratio of -5.80 and a beta of 1.20.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings data on Thursday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The firm had revenue of $82.37 million during the quarter, compared to analysts’ expectations of $78.07 million. As a group, sell-side analysts anticipate that Beauty Health will post -0.25 earnings per share for the current fiscal year.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.